News
Vertex shares fell in after-hours trading, as investors considered a stock trading near its all-time high with a longer wait ...
Vertex Pharmaceuticals reports first-quarter financial results after the market close on Monday. Here's a look at the key highlights from the period.
Vertex said its profit fell due to higher operating expenses and a $379 million intangible asset impairment charge associated with treatment for Type 1 diabetes patients, which the company said in ...
BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Monday reported first-quarter profit of $646.3 million. On a per-share basis, the Boston-based company said it had net income of $2.49 ...
F.N.B. Corporation announced its Board of Directors declared a quarterly cash dividend of $0.12 per share on its common stock. The dividend is payable on June 15, 2025, to shareholders of record as of ...
Vertex Pharmaceuticals missed Wall Street estimates for quarterly results on Monday, due to lower-than-expected sales of its ...
The stock's fall snapped a seven-day winning streak.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
ToolGen commences legal action in UK court over Vertex's genome editing therapy, CASGEVY ®Seeks to expand licensing of its proprietary CRISPR RNP technologySEOUL, South Korea, April 21, 2025 /PRNewswi ...
Daily Wrap on MSN18d
Time's 100 most influential: A global who's who unveiledThe list of the 100 most influential people in the world. Among those recognised are artists, politicians, business leaders, activists, and innovators. Who made it onto this prestigious list? What do ...
Noa Argamani, a Hamas captivity survivor, was named in Time's annual list of the 100 most influential people of the year 2025. Argamani was held captive by Hamas after being abducted from Israel on ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results